Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-25 @ 4:13 PM
Study NCT ID:
NCT00048659
Status:
TERMINATED
Last Update Posted:
2012-06-07
First Post:
2002-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-06
Completion Date Type:
ACTUAL
First Submit Date:
2002-11-04
First Submit QC Date:
None
Study First Post Date:
2002-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-06
Last Update Post Date:
2012-06-07
Last Update Post Date Type:
ESTIMATED